|
 |
| home > epc > autumn 2003 > recruiting hiv infected patients for anti-retroviral clinical trials in cee and the russian federation |
|
|
 PUBLICATIONS |
European Pharmaceutical Contractor
|
| Over the past decade the number of international clinical trials performed in Central and Eastern Europe (CEE) has continuously increased. Amongst these countries, Poland has become a regular partner in the conduct of clinical trials although this is not yet the case for most other CEE countries. Since the start of the first trial in the Russian Federation only about 120 trials have been conducted there (1). However, given the positive aspects of performing clinical trials in CEE countries and the Russian Federation, one can expect the number of trials to increase over time. To explain, site staff tend to be very motivated and eager to participate in clinical trials, while the quality of work and ICH GCP compliance is largely impeccable. Even more important when conducting clinical trials, recruitment in CEE countries and the Russian Federation appears to be higher than in most Western European countries. This again is not only because of the motivated staff but also because of the availability of the potential trial population. |
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
4th Annual Patient Recruitment and Retention in Clinical Trials
13-15 October 2008, Amsterdam
Patient recruitment
is now consuming thirty percent of clinical trial time - more time than any
other clinical trial activity - and almost half of all trial delays result from
patient recruitment problems.
As the
recruiting culture becomes more sophisticated and the forces affecting patient
enrollment grow more numerous and complex, pharmaceutical companies are
striving to discover new strategies to facilitate enrollment in clinical
trials.
With
increasing industry pressure to develop, test and market greater numbers of new
drugs faster, pharmaceutical companies need to perform clinical trials as
quickly as possible. Inefficient patient recruitment processes is a formidable
barrier to pharmaceutical companies' success in launching new products.
Improving the patient recruitment process is imperative to avoid wasted
investments and eliminate costly delays in bringing new drugs to market --
today and even more so in the not-so-distant future. Improved patient
recruitment presents one of the largest opportunities for pharmaceutical
companies to eliminate delays in clinical trials, thereby making it possible to
reduce time to market. With patent time limits and large overheads
meaning that any delays in the development timeline can be disastrous, a good
understanding of how to successfully recruit patients for trials is vital for
any company looking to succeed.
More info >> |
|
 |
News and Press Releases |
 |
MipTec, October 14 – 16, 2008, Switzerland
MipTec about to take off by joining forces between Life Sciences Week, ALL-SystemsX.ch-Day, & Jobvector.com
More info >> |
|
 |
